These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. Siris ES; Sherman WH; Baquiran DC; Schlatterer JP; Osserman EF; Canfield RE N Engl J Med; 1980 Feb; 302(6):310-5. PubMed ID: 6444241 [TBL] [Abstract][Full Text] [Related]
3. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton. Siris ES; Hyman GA; Canfield RE Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577 [TBL] [Abstract][Full Text] [Related]
4. Dichloromethylene diphosphonate action in hematologic and other malignancies. Canfield RE; Siris ES; Jacobs TP Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Merlini G; Parrinello GA; Piccinini L; Crema F; Fiorentini ML; Riccardi A; Pavesi F; Novazzi F; Silingardi V; Ascari E Hematol Oncol; 1990; 8(1):23-30. PubMed ID: 2137106 [TBL] [Abstract][Full Text] [Related]
6. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate. Attardo-Parrinello G; Merlini G; Pavesi F; Crema F; Fiorentini ML; Ascari E Arch Intern Med; 1987 Sep; 147(9):1629-33. PubMed ID: 2957971 [TBL] [Abstract][Full Text] [Related]
7. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma. Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750 [TBL] [Abstract][Full Text] [Related]
8. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone. Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781 [TBL] [Abstract][Full Text] [Related]
9. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone. Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate. Delmas PD; Chapuy MC; Meunier PJ Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216 [TBL] [Abstract][Full Text] [Related]
11. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone. Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215 [TBL] [Abstract][Full Text] [Related]
12. Use of dichloromethylene diphosphonate in metastatic bone disease. Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257 [TBL] [Abstract][Full Text] [Related]
13. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389 [TBL] [Abstract][Full Text] [Related]
14. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate. Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846 [TBL] [Abstract][Full Text] [Related]
15. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate. Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978 [TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications. Clemens MR; Fessele K; Heim ME Ann Hematol; 1993 Mar; 66(3):141-6. PubMed ID: 8471660 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism. Elomaa I; Blomqvist C; Porkka L; Holmström T; Laine H Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989 [TBL] [Abstract][Full Text] [Related]
18. The use of clodronate in multiple myeloma. Delmas PD Bone; 1991; 12 Suppl 1():S31-4. PubMed ID: 1835398 [TBL] [Abstract][Full Text] [Related]
19. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism. Shane E; Baquiran DC; Bilezikian JP Ann Intern Med; 1981 Jul; 95(1):23-7. PubMed ID: 6264825 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man. McCloskey EV; Yates AJ; Beneton MN; Galloway J; Harris S; Kanis JA Bone; 1987; 8 Suppl 1():S35-41. PubMed ID: 2825741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]